A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION

被引：0
|
作者：
Lee, H. [1 ]
Park, S. [2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Samsung Hosp, Seoul, South Korea
来源：
JOURNAL OF HYPERTENSION | 2017年 / 35卷
关键词：
D O I：
10.1097/01.hjh.0000523533.01598.7c
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.12.23
引用
收藏
页码：E193 / E193
页数：1
相关论文
共 50 条
  • [31] Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential HypertensionAn 8-Week, Randomized, Double-Blind, Factorial, Phase II, Multicenter Study
    Chang-Gyu Park
    Ho-Joong Youn
    Shung-Chull Chae
    Joo-Young Yang
    Moo-Hyun Kim
    Taek-Jong Hong
    Cheol Ho Kim
    Jae Joong Kim
    Bum-Kee Hong
    Jin-Won Jeong
    Si-Hoon Park
    Jun Kwan
    Young-Jin Choi
    Seung-Yun Cho
    American Journal of Cardiovascular Drugs, 2012, 12 : 35 - 47
  • [32] EFFICACY AND SAFETY OF COMBINATION OF TOLTERODINE AND PILOCARPINE IN OVERACTIVE BLADDER PATIENTS: A RANDOMIZED DOUBLE-BLIND MULTICENTER PHASE 3 STUDY
    Lee, K.
    Ko, K. J.
    Yoon, S. J.
    Kim, S. W.
    Kim, S.
    Seo, J. T.
    Choo, M.
    Lee, S. W.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S45 - S46
  • [33] The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study
    Zhuang, Qianjun
    Liao, Aijun
    He, Qingling
    Liu, Chengxia
    Zheng, Changqing
    Li, Xing
    Liu, Youli
    Wang, Bangmao
    Liu, Side
    Zhang, Yan
    Lin, Rong
    Chen, Huixin
    Deng, Min
    Tang, Yanping
    He, Chiyi
    Dai, Weijie
    Tang, Haitao
    Gong, Lei
    Li, Liangping
    Xu, Baohong
    Yang, Changqing
    Zhou, Bingxi
    Su, Dongxing
    Guo, Qinghong
    Li, Bin
    Zhou, Yongjian
    Wang, Xiaoyang
    Fei, Sujuan
    Wu, Huili
    Wei, Sichen
    Peng, Zhihong
    Wang, Jianning
    Li, Yanqing
    Wang, Hong
    Deng, Tianwei
    Ding, Shigang
    Li, Fangfang
    Chen, Minhu
    Xiao, Yinglian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (04) : 658 - 666
  • [34] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Hiroyoshi Ohta
    Hiroshi Oka
    Chie Usui
    Masayuki Ohkura
    Makoto Suzuki
    Kusuki Nishioka
    Arthritis Research & Therapy, 14
  • [35] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [36] Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial
    Sohn, Il Suk
    Kim, Chong-Jin
    Ahn, Taehoon
    Youn, Ho-Joong
    Jeon, Hui-Kyung
    Ihm, Sang Hyun
    Cho, Eun Joo
    Chung, Woo-Baek
    Chae, Shung Chull
    Kim, Woo-Shik
    Nam, Chang-Wook
    Park, Seong-Mi
    Choi, Ji-Yong
    Kim, Young-Kwon
    Hong, Taek-Jong
    Lee, Hae-Young
    Cho, Jang-Hyun
    Shin, Eun-Seok
    Yoon, Jung-Han
    Yang, Tae-Hyun
    Jeong, Myung-Ho
    Lee, Jun-Hee
    Park, Joong-Il
    CLINICAL THERAPEUTICS, 2017, 39 (08) : 1628 - 1638
  • [37] Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial
    Hong, Soon Jun
    Jeong, Han Saem
    Cho, Jin-Man
    Chang, Kiyuk
    Pyun, Wook Bum
    Ahn, Youngkeun
    Hyon, Min Su
    Kang, Woong Chol
    Lee, Jae-Hwan
    Kim, Hyo-Soo
    CLINICAL THERAPEUTICS, 2019, 41 (02) : 233 - 248
  • [38] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Hiromi Rakugi
    Kazuomi Kario
    Masako Yamaguchi
    Takayoshi Sasajima
    Hiromi Gotou
    Jack Zhang
    Hypertension Research, 2022, 45 : 824 - 833
  • [39] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Rakugi, Hiromi
    Kario, Kazuomi
    Yamaguchi, Masako
    Sasajima, Takayoshi
    Gotou, Hiromi
    Zhang, Jack
    HYPERTENSION RESEARCH, 2022, 45 (05) : 824 - 833
  • [40] Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study
    Rakugi, Hiromi
    Kario, Kazuomi
    Yamaguchi, Masako
    Sasajima, Takayoshi
    Gotou, Hiromi
    Zhang, Jack
    HYPERTENSION RESEARCH, 2022,
12345